Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

GLYX 13

Base Information Edit
  • Chemical Name:GLYX 13
  • CAS No.:117928-94-6
  • Molecular Formula:C18H31N5O6
  • Molecular Weight:413.474
  • Hs Code.:
  • Mol file:117928-94-6.mol
GLYX 13

Synonyms:GLYX 13

Suppliers and Price of GLYX 13
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Usbiological
  • GLYX 13
  • 1mg
  • $ 389.00
  • TRC
  • GLYX-13
  • 1mg
  • $ 60.00
  • Tocris
  • GLYX13
  • 1
  • $ 150.00
  • Sigma-Aldrich
  • GLYX-13 trifluoroacetate ≥98% (HPLC)
  • 1mg
  • $ 179.00
  • DC Chemicals
  • Rapastinel(GLYX-13) >98%
  • 1 g
  • $ 1300.00
  • DC Chemicals
  • Rapastinel(GLYX-13) >98%
  • 100 mg
  • $ 450.00
  • CSNpharm
  • Rapastinel
  • 25mg
  • $ 1023.00
  • Crysdot
  • Rapastinel 98+%
  • 25mg
  • $ 1140.00
  • Crysdot
  • Rapastinel 98+%
  • 5mg
  • $ 321.00
  • Crysdot
  • Rapastinel 98+%
  • 10mg
  • $ 518.00
Total 92 raw suppliers
Chemical Property of GLYX 13 Edit
Chemical Property:
  • Boiling Point:844.212 °C at 760 mmHg 
  • PKA:12.26±0.45(Predicted) 
  • Flash Point:464.363 °C 
  • PSA:179.29000 
  • Density:1.37 g/cm3 
  • LogP:-1.30530 
  • Storage Temp.:?20°C 
Purity/Quality:

98% *data from raw suppliers

GLYX 13 *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Uses Rapastinel is a novel antidepressant drug approved as an adjunctive therapy for the treatment of treatment-resistant major depressive disorder. It is a centrally active, intravenously administered (non-orally active) amidated tetrapeptide (Thr-Pro-Pro-Thr-NH2) that acts as a selective, weak partial agonist (mixed antagonist/agonist) of an allosteric site at the glycine site of the NMDA receptor complex (Emax ≈ 25%).The drug is a rapid-acting and long-lasting antidepressant as well as robust cognitive enhancer by virtue of its ability to both inhibit and enhance NMDA receptor-mediated signal transduction. GLYX-13 is a long lasting and rapid acting antidepressant. Investigational drug for the treatment of depressive disoder. GLYX-13 trifluoroacetate has been used as an activator of NMDA (N-methyl-D-aspartate) receptor.
Technology Process of GLYX 13

There total 19 articles about GLYX 13 which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Guidance literature:
Fmoc-Thr(tBu)-OH; With piperidine; O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 80 ℃; for 0.0833333h; Rink amide resin
With piperidine; In N,N-dimethyl-formamide; at 80 ℃; for 0.0333333h; Rink amide resin
Fmoc-Pro-OH; Fmoc-Thr(tBu)-OH; Further stages;
DOI:10.1021/acs.joc.1c01906
Post RFQ for Price